Monoclonal antibody for colorectal carcinoma
US4892933A · kind A · utility
5Cited by
1References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 20, 1988 |
| Grant date | Jan 9, 1990 |
| Priority date | — |
| Expiry date | Apr 20, 2008 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/809
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A monoclonal antibody raised to colorectal carcinoma, and a hybridoma which elicits the antibody, have been produced. This antibody, ND4 has been discovered to react with a new tumor marker, a glycoprotein of approximately 160 kD found on the surface of undifferentiated colorectal carcinoma cells; it does not cross-react with other known tumor markers. It is useful for detecting and monitoring colorectal carcinoma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.